Subscribe To
Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
ALLSCHWIL, Switzerland, Sept. 27, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that the company has appointed Gonçalo Bernardes, PhD, as acting Head of Chemical Biology. Dr. Bernardes is a leader in the fields of chemistry and oncology and currently a Full Professor […] The post Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology appeared first on Forex...
Read More
Posted: Sep 28 2023, 05:30
Author Name: forextv
Views: 111253